Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,627,000 | 2,388,000 | 1,022,000 | 1,774,000 | 2,584,000 |
| Depreciation Amortization | 575,000 | 348,000 | 158,000 | 786,000 | 593,000 |
| Accounts receivable | -842,000 | -588,000 | -544,000 | -172,000 | 95,000 |
| Accounts payable and accrued liabilities | 1,328,000 | 409,000 | 188,000 | -193,000 | -1,000 |
| Other Working Capital | 861,000 | 357,000 | 159,000 | -354,000 | 178,000 |
| Other Operating Activity | 23,000 | 503,000 | 602,000 | 1,708,000 | 678,000 |
| Operating Cash Flow | $5,572,000 | $3,417,000 | $1,585,000 | $3,549,000 | $4,127,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -387,000 | -260,000 | -145,000 | -612,000 | -459,000 |
| Net Acquisitions | -12,282,000 | -12,282,000 | -736,000 | -622,000 | -572,000 |
| Purchase Of Investment | -851,000 | -851,000 | 0 | -1,169,000 | -1,169,000 |
| Sale Of Investment | 881,000 | 9,000 | 8,000 | 1,477,000 | 1,460,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -2,700,000 |
| Investing Cash Flow | $-12,639,000 | $-13,384,000 | $-873,000 | $-926,000 | $-3,440,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 335,000 | -425,000 | 144,000 | 12,000 | -112,000 |
| Debt Issued | 16,660,000 | 16,655,000 | N/A | N/A | N/A |
| Debt Repayment | -15,000 | -11,000 | N/A | -17,000 | N/A |
| Common Stock Issued | 123,000 | 101,000 | 47,000 | 232,000 | 164,000 |
| Common Stock Repurchased | -6,342,000 | -5,344,000 | -342,000 | -665,000 | -352,000 |
| Dividend Paid | -2,454,000 | -1,604,000 | -786,000 | -2,661,000 | -1,987,000 |
| Other Financing Activity | -124,000 | -133,000 | 7,000 | -194,000 | -124,000 |
| Financing Cash Flow | $8,183,000 | $9,239,000 | $-930,000 | $-3,293,000 | $-2,411,000 |
| Exchange Rate Effect | -241,000 | -220,000 | -224,000 | -577,000 | -152,000 |
| Beginning Cash Position | 8,348,000 | 8,348,000 | 8,348,000 | 9,595,000 | 9,595,000 |
| End Cash Position | 9,223,000 | 7,400,000 | 7,906,000 | 8,348,000 | 7,719,000 |
| Net Cash Flow | $875,000 | $-948,000 | $-442,000 | $-1,247,000 | $-1,876,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,572,000 | 3,417,000 | 1,585,000 | 3,549,000 | 4,127,000 |
| Capital Expenditure | -387,000 | -260,000 | -145,000 | -612,000 | -459,000 |
| Free Cash Flow | 5,185,000 | 3,157,000 | 1,440,000 | 2,937,000 | 3,668,000 |